Ethanol

India Ethanol Market Size to Surpass Around US$ 6.83 Billion 2030, Recording a CAGR of 15.9% | Report by CoherentMI

Retrieved on: 
Friday, February 16, 2024
Air pollution, Adhesive, Toxicity, Cosmetics, Investment, Gasoline, Ethanol, Molasses, Pollution, Growth, Government, IOCL, Fossil, Segment, Biofuel, Renewable energy

This trend is expected to contribute to the growth of the India Ethanol Market in the coming years.

Key Points: 
  • This trend is expected to contribute to the growth of the India Ethanol Market in the coming years.
  • The first market opportunity in the India Ethanol Market is the increasing demand for ethanol as a fuel source.
  • The second market opportunity in the India Ethanol Market is the growing demand for ethanol in industrial applications.
  • India Ethanol Market is anticipated to witness a CAGR of 15.9% during the forecast period 2023-2030, owing to the growing demand for ethanol in industrial applications.

Autonomix Begins Human POC Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market

Retrieved on: 
Friday, February 16, 2024
Nervous system, POC, AMIX, Collateral damage, Pain, Principal investigator, Patient, Disease, Trial of the century, Ethanol, Medical imaging

THE WOODLANDS, TX, Feb. 16, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced the completion of its site initiation for its proof-of-concept human clinical study evaluating the use of transvascular RF ablation for the treatment of pancreatic cancer pain.

Key Points: 
  • “We continue to make solid progress with our PoC human clinical study.
  • This study is a very important step in validating our clinical and regulatory plans for our technology and as such our team is dedicated to its successful execution.
  • The primary objective of the proof-of-concept human clinical study is to successfully ablate relevant somatic nerves and mitigate pain in patients with pancreatic cancer pain utilizing RF ablation in a transvascular approach to the nerves in the region.
  • Twenty (20) subjects will be enrolled at one clinical trial site for the study.

Herbal medicinal product: Agni casti fructusArray, C: ongoing call for scientific data

Retrieved on: 
Friday, February 16, 2024
Woman, Committee, Acne, Monograph, Headache, Chronic pain, Breast, Hypothalamus, Dizziness, Nausea, Date, Mouth, Urinary system, Safety, Stomach, Premenstrual syndrome, Pituitary gland, Allergy, Rash, Patient, Fruit, Medicine, DSM-IV codes, Herbal medicine, Irritability, Ethanol, Brain, Dietary supplement

Herbal medicinal product: Agni casti fructusArray, C: ongoing call for scientific data

Key Points: 


Herbal medicinal product: Agni casti fructusArray, C: ongoing call for scientific data

Herbal medicinal product: Echinaceae purpureae radixArray, C: ongoing call for scientific data

Retrieved on: 
Friday, February 16, 2024
Pimple, Allergy, Committee, Acne, Asteraceae, Plant, Date, Echinacea, Mouth, Patient, Medicine, Herbal medicine, Water, Ethanol

Overview

Key Points: 
  • Overview
    This is a summary of the scientific conclusions reached by the Committee on Herbal Medicinal Products (HMPC) on the medicinal uses of purple coneflower root.
  • The HMPC conclusions are taken into account by EU Member States when evaluating applications for the licensing of herbal medicines containing purple coneflower root.
  • Purple coneflower root preparations may also be found in combination with other herbal substances in some herbal medicines.
  • Key facts
    - Latin name
    - Echinaceae purpureae radix
    - English common name
    - Purple Coneflower Root
    - Botanical name
    Echinacea purpurea (L.) Moench.

Herbal medicinal product: Cimicifugae rhizomaArray, C: ongoing call for scientific data

Retrieved on: 
Friday, February 16, 2024
Woman, Committee, Ethanol, Liver, Skin, Nausea, Vomiting, Date, Mouth, Urinary system, Safety, Somatic symptom disorder, Diarrhea, Itch, Rash, Patient, Medicine, Urine, Indigestion, Extremities, Herbal medicine, Fatigue, Face, Perspiration

Overview

Key Points: 
  • Overview
    This is a summary of the scientific conclusions reached by the Committee on Herbal Medicinal Products (HMPC) on the medicinal uses of black cohosh.
  • The HMPC conclusions are taken into account by EU Member States when evaluating applications for the licensing of herbal medicines containing black cohosh.
  • Black cohosh preparations may also be found in combination with other herbal substances in some herbal medicines.
  • - Therapeutic area
    - Urinary tract and genital disorders
    - Status
    - C: ongoing call for scientific data
    - Date added to the inventory
    - Date added to priority list
    - Outcome of European assessment
    - European Union herbal monograph

Autonomix Medical, Inc. Reports Third Quarter FY2024 Financial Results and Reiterates Upcoming Key Milestones

Retrieved on: 
Wednesday, February 14, 2024
Engineering, Ethics committee, Nervous system, Research, POC, AMIX, Collateral damage, Marketing, Quality of life, Pain, Calendar, Ethics, IPO, Advertising, Launch, Completeness, Patient, Clinical trial, Disease, Pancreatic cancer, Trial of the century, Ethanol, Medical imaging

THE WOODLANDS, TX, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, reported financial results yesterday for the third quarter FY2024 ended December 31, 2023 and provided a corporate update.

Key Points: 
  • “I am incredibly pleased with the progress we have made on the corporate, financial and clinical fronts in such a short period of time.
  • We are grateful for the continued support and remain focused on successfully executing on the milestones laid out ahead of us,” commented Lori Bisson, Chief Executive Officer of Autonomix.
  • Achieving “proof-of-concept” in this area could open the door to blockbuster diseases, expanding the horizons for the Company’s technology.
  • Summary of Financial Results for Q3 FY2024 Ended December 31, 2023
    For the nine months ended December 31, 2023 and 2022, the Company incurred net losses of $10.0 million and $1.3 million, respectively.

EQS-News: Q2 2023/24: Verbio holds its own in a volatile market environment

Retrieved on: 
Thursday, February 8, 2024
Ethanol, Pressure, SBE, Verbio, Grain, Biodiesel, Biomass, Tax, GHG, Investment, Bitterfeld, CO2, Depreciation, Kilowatt-hour, Acquisition, HVO, EUR, Eye

In doing so Verbio generated Group revenue of EUR 908.9 million in the 1 HY 2023/24 (1 HY 2022/23: EUR 1,077.7 million).

Key Points: 
  • In doing so Verbio generated Group revenue of EUR 908.9 million in the 1 HY 2023/24 (1 HY 2022/23: EUR 1,077.7 million).
  • In addition, Verbio was able to increase the production volume of biomethane to 275.9 GWh in Q2 2023/24, from 261.1 GWh in Q2 2022/23.
  • As a result, Verbio generated an EBITDA of EUR -5.2 million (Q2 2022/23: EUR 1.7 million).
  • Verbio invested EUR 54.2 million in property, plant and equipment in the second quarter of 2023/24 (Q2 2022/23: EUR 52.0 million).

National Corn Growers Association: Thousands of Farmers Across the Country Caution Biden Administration Against Solely Focusing on Electric Vehicles at Expense of Biofuels in Climate Fight

Retrieved on: 
Wednesday, February 7, 2024
Ethanol, Greenhouse gas, National Corn Growers Association, Congress, Legislation, Agriculture, Climate change, Biofuel, NCGA, Carbon, Farmer, EVS, EPA, Letter, Renewable energy

To help meet the standards, the president has set a goal that 50% of all vehicle sales will be electric by 2030.

Key Points: 
  • To help meet the standards, the president has set a goal that 50% of all vehicle sales will be electric by 2030.
  • A similar rulemaking is also being considered through the National Highway Traffic Safety Administration.
  • Corn growers have urged Congress to pass legislation that would allow for higher levels of ethanol blends year-round.
  • NCGA is also pushing to advance the Next Generation Fuels Act, which would lower fuel prices, reduce carbon emissions and help shore-up America's energy security.

Fueling the Future: Biofuels Global Market Soars to $125.9 Billion in 2023, Eyes $143.8 Billion by 2028: BCC Research Analyst

Retrieved on: 
Tuesday, February 6, 2024
Carbon, Nature, Ethanol, Plant, Growth, Research, Incentive, Transport, International finance, Biofuel, Low-carbon fuel standard, LCFS, Air travel, SAF, Renewable energy

BOSTON, Feb. 6, 2024 /PRNewswire/ -- Discover the amazing world of Biofuels: Global Markets – where nature and technology team up for a cleaner planet! Dive into the story of renewable energy that's changing the game globally. Learn how biofuels are making our world greener and energy smarter. It's not just about fuel; it's about a brighter, cleaner future for us all. This is the story of how biofuels are changing the way we power our world, making it greener and more sustainable. Get ready to explore the exciting global market of biofuels and the positive impact it's having on our planet.

Key Points: 
  • This is the story of how biofuels are changing the way we power our world, making it greener and more sustainable.
  • Get ready to explore the exciting global market of biofuels and the positive impact it's having on our planet.
  • The final sections showcase a competitive landscape of the global biofuel market and explore emerging technologies in the sector.
  • These measures contribute to the growth of the biofuels market, fostering a cleaner and more environmentally friendly energy sector.